TY - JOUR
T1 - Inducible Membrane Permeabilization by Attenuated Lytic Peptides
T2 - A New Concept for Accessing Cell Interiors through Ruffled Membranes
AU - Akishiba, Misao
AU - Futaki, Shiroh
N1 - Funding Information:
This work was supported by JSPS KAKENHI (Grant Numbers 18H04403 and 18H04017), and in part by JST CREST (Grant Number JPMJCR18H5). M.A. is grateful for the JSPS Research Fellowship for Young Scientists. The authors are grateful to Professors T. Yoshimori and H.-W. Shin for GFP-Gal3 and EGFP-Rab5 plasmids. We are grateful to E. Naganuma and Dr. T. Hanaichi (Hanaichi UltraStructure Research Institute) for their technical assistance with the electron microscopic observations.
Publisher Copyright:
© 2019 American Chemical Society.
PY - 2019/6/3
Y1 - 2019/6/3
N2 - A variety of mid-sized and large biomolecules have been used as tools to explore fundamental biological questions. However, such molecules are often cell-impermeable and thus unable to attain sufficient access to the cell interior. This inhibits their ability to yield analytical data about the cell interior or modify the cellular events. We have recently developed a peptide, engineered from a natural hemolytic peptide, named L17E. Substantial cytosolic delivery of biomacromolecules, including antibodies, was attained in the presence of this peptide. In this study, detailed analysis of the modes of action of L17E was conducted, elucidating that a large fraction of the cytosolic translocation of biomacromolecules is accomplished in the presence of L17E within 5 min. L17E stimulates actin polymerization and induces a dynamic structural alteration of cell membranes, resulting in a ruffled appearance. Studies using macropinocytosis inhibitors and proteins that control endosome maturation raise the possibility that the transient permeabilization of ruffled cell membranes, rather than the rupture of endosomal membranes, is the crucial mechanism for facile cytosolic translocation of biomacromolecules in the presence of L17E. Our results provide a distinct concept of intracellular delivery, different from direct translocation through cell membranes or endocytic uptake followed by endosomal escape. This method of permeabilization via membrane ruffling provides a novel concept in intracellular delivery.
AB - A variety of mid-sized and large biomolecules have been used as tools to explore fundamental biological questions. However, such molecules are often cell-impermeable and thus unable to attain sufficient access to the cell interior. This inhibits their ability to yield analytical data about the cell interior or modify the cellular events. We have recently developed a peptide, engineered from a natural hemolytic peptide, named L17E. Substantial cytosolic delivery of biomacromolecules, including antibodies, was attained in the presence of this peptide. In this study, detailed analysis of the modes of action of L17E was conducted, elucidating that a large fraction of the cytosolic translocation of biomacromolecules is accomplished in the presence of L17E within 5 min. L17E stimulates actin polymerization and induces a dynamic structural alteration of cell membranes, resulting in a ruffled appearance. Studies using macropinocytosis inhibitors and proteins that control endosome maturation raise the possibility that the transient permeabilization of ruffled cell membranes, rather than the rupture of endosomal membranes, is the crucial mechanism for facile cytosolic translocation of biomacromolecules in the presence of L17E. Our results provide a distinct concept of intracellular delivery, different from direct translocation through cell membranes or endocytic uptake followed by endosomal escape. This method of permeabilization via membrane ruffling provides a novel concept in intracellular delivery.
UR - http://www.scopus.com/inward/record.url?scp=85066796628&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066796628&partnerID=8YFLogxK
U2 - 10.1021/acs.molpharmaceut.9b00156
DO - 10.1021/acs.molpharmaceut.9b00156
M3 - Article
C2 - 30945865
AN - SCOPUS:85066796628
SN - 1543-8384
VL - 16
SP - 2540
EP - 2548
JO - Molecular pharmaceutics
JF - Molecular pharmaceutics
IS - 6
ER -